MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202441011008 A) filed by Dr. Reddy's Laboratories Limited, Hyderabad, Telangana, on Feb. 16, 2024, for 'system and method for providing personalized condition management for regulating irritable bowel syndrome (ibs).'
Inventor(s) include Kolwankar, Siddhesh Santosh; Sankuri, Adharsh; Reddy, Anuj; and Anand, Manish.
The application for the patent was published on Sept. 5, under issue no. 36/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a system (102) and a method (300) for personalized health management to provide recommendations for a user diagnosed with IBS and related symptoms. The method (300) includes receiving (302) user datasets, determining (304) a current IBS symptom score, and computing (306) a target IBS symptom score. A personalized plan is recommended, initiating (308) a gut cleansing phase to arrive at a first IBS symptom score and assessing (310) and revising the plan for a reintroduction phase to determine a second IBS symptom score. Further, assessing (312) identifies symptom triggers, refining the plan to arrive at a third IBS symptom score. At a sustenance phase, assessing (314) determines long-term impacts and revises the plan to maintain the target IBS symptom score. Therefore, the present disclosure provides a data-driven, adaptive system for dynamic IBS management, ensuring sustained improvement and symptom control."
Disclaimer: Curated by HT Syndication.
